Mechanistically, ELAVL1 promotes the expression of interleukin (IL)-8, which has clear connections with the progression of breast cancer, via binding to the 3′-UTR of the mRNA encoding IL-1β (Suswam et al., 2005). The gene discussed is ELAVL1; the disease is breast cancer.